{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:13:57Z","timestamp":1785276837428,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00415-024-12317-0","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T11:01:53Z","timestamp":1712314913000},"page":"4119-4130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis"],"prefix":"10.1007","volume":"271","author":[{"given":"Laura","family":"Mart\u00ednez-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Calvet","family":"Lacruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Querol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cort\u00e9s-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Rojas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reyes-Leiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"\u00c1lvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ndido","family":"Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-4793","authenticated-orcid":false,"given":"Ana\u00eds","family":"Mariscal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The 2022 GEAI-S. E. I. Workshop participants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"12317_CR1","doi-asserted-by":"publisher","first-page":"7288","DOI":"10.3390\/ijms24087288","volume":"24","author":"A Shastri","year":"2023","unstructured":"Shastri A, Al Aiyan A, Kishore U, Farrugia ME (2023) Immune-mediated neuropathies: pathophysiology and management. Int J Mol Sci 24:7288. https:\/\/doi.org\/10.3390\/ijms24087288","journal-title":"Int J Mol Sci"},{"key":"12317_CR2","first-page":"383","volume-title":"Handbook of clinical neurology","author":"H Fujimura","year":"2013","unstructured":"Fujimura H (2013) The Guillain-Barr\u00e9 syndrome. Handbook of clinical neurology. Elsevier, New York, pp 383\u2013402"},{"key":"12317_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA (2016) Guillain-Barr\u00e9 syndrome. The Lancet 388:717\u2013727. https:\/\/doi.org\/10.1016\/S0140-6736(16)00339-1","journal-title":"The Lancet"},{"key":"12317_CR4","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1007\/s00415-015-7806-4","volume":"262","author":"M Koga","year":"2015","unstructured":"Koga M, Takahashi M, Yokoyama K, Kanda T (2015) Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barr\u00e9 syndrome and its variants. J Neurol 262:1954\u20131960. https:\/\/doi.org\/10.1007\/s00415-015-7806-4","journal-title":"J Neurol"},{"key":"12317_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002063.pub6","author":"RA Hughes","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA (2014) Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD002063.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"12317_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jnnp.2009.183517","volume":"81","author":"R Rojas-Garcia","year":"2010","unstructured":"Rojas-Garcia R, Gallardo E, De Luna N et al (2010) Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(2\u20133)Gal. J Neurol Neurosurg Psychiatry 81:623\u2013628. https:\/\/doi.org\/10.1136\/jnnp.2009.183517","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12317_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1529-8027.2012.00407.x","volume":"17","author":"Rojas-Garc\u00eda","year":"2012","unstructured":"Rojas-Garc\u00eda et al (2012) Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies. J Peripher Nerv Syst 17:158\u2013168","journal-title":"J Peripher Nerv Syst"},{"key":"12317_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA et al (2019) Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol 15:671\u2013683. https:\/\/doi.org\/10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"12317_CR9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ana.410230503","volume":"23","author":"AA Ilyas","year":"1988","unstructured":"Ilyas AA, Willison HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD, Griffin DE, Griffin JW, McKhann GM (1988) Serum antibodies to gangliosides in Guillain-Barr\u00e9 syndrome. Ann Neurol 23(5):440\u2013447","journal-title":"Ann Neurol"},{"key":"12317_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.31138\/mjr.31.1.10","volume":"31","author":"D Roggenbuck","year":"2019","unstructured":"Roggenbuck D, Delmont E, Reinhold D et al (2019) Autoimmune peripheral neuropathies and contribution of antiganglioside\/sulphatide autoantibody testing. Mediterr J Rheumatol. 31:10. https:\/\/doi.org\/10.31138\/mjr.31.1.10","journal-title":"Mediterr J Rheumatol."},{"key":"12317_CR11","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","volume":"124","author":"HJ Willison","year":"2001","unstructured":"Willison HJ (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 124:1968\u20131977. https:\/\/doi.org\/10.1093\/brain\/124.10.1968","journal-title":"Brain"},{"key":"12317_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/mus.22172","volume":"44","author":"C Paradas","year":"2011","unstructured":"Paradas C, Morgado Y, Gallardo E et al (2011) Prednisone can worsen ataxic neuropathy with anti-disialosyl IgM antibodies. Muscle Nerve 44:839\u2013840. https:\/\/doi.org\/10.1002\/mus.22172","journal-title":"Muscle Nerve"},{"key":"12317_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s00415-008-0803-0","volume":"255","author":"R Rojas-Garcia","year":"2008","unstructured":"Rojas-Garcia R, Gallardo E, Povedano M et al (2008) Antibodies against disialosyl and terminal NeuNAc(\u03b12-3)Gal ganglioside epitopes in acute relapsing sensory ataxic neuropathy. J Neurol 255:764\u2013766. https:\/\/doi.org\/10.1007\/s00415-008-0803-0","journal-title":"J Neurol"},{"key":"12317_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jnnp.2009.185736","volume":"81","author":"S Attarian","year":"2010","unstructured":"Attarian S, Boucraut J, Hubert AM et al (2010) Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy. J Neurol Neurosurg Psychiatry 81:61\u201364. https:\/\/doi.org\/10.1136\/jnnp.2009.185736","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12317_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00415-009-5412-z","volume":"257","author":"E Delmont","year":"2010","unstructured":"Delmont E, Jeandel PY, Hubert AM et al (2010) Successful treatment with rituximab of one patient with CANOMAD neuropathy. J Neurol 257:655\u2013657. https:\/\/doi.org\/10.1007\/s00415-009-5412-z","journal-title":"J Neurol"},{"key":"12317_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/jnnp-2013-305755","volume":"85","author":"E Nobile-Orazio","year":"2014","unstructured":"Nobile-Orazio E, Giannotta C, Musset L et al (2014) Sensitivity and predictive value of anti-GM1\/galactocerebroside IgM antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 85:754\u2013758. https:\/\/doi.org\/10.1136\/jnnp-2013-305755","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12317_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jneuroim.2009.11.012","volume":"219","author":"E Nobile-Orazio","year":"2010","unstructured":"Nobile-Orazio E, Giannotta C, Briani C (2010) Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies. J Neuroimmunol 219:119\u2013122. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.11.012","journal-title":"J Neuroimmunol"},{"issue":"3","key":"12317_CR18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ana.410360313","volume":"36","author":"E Nobile-Orazio","year":"1994","unstructured":"Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, Bonetti B, Cavaletti G, Gemignani F, Durelli L et al (1994) Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36(3):416\u2013424","journal-title":"Ann Neurol"},{"issue":"9","key":"12317_CR19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/WNL.0b013e3181b59a80","volume":"73","author":"ML Kuijf","year":"2009","unstructured":"Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, van den Berg LH, Hooijkaas H, Stork J, Notermans NC, Jacobs BC (2009) Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology 73(9):688\u2013695","journal-title":"Neurology"},{"key":"12317_CR20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.autrev.2013.03.002","volume":"12","author":"P Zisimopoulou","year":"2013","unstructured":"Zisimopoulou P, Brenner T, Trakas N, Tzartos SJ (2013) Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens. Autoimmun Rev 12:924\u2013930. https:\/\/doi.org\/10.1016\/j.autrev.2013.03.002","journal-title":"Autoimmun Rev"},{"key":"12317_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.596981","volume":"11","author":"K Lazaridis","year":"2020","unstructured":"Lazaridis K, Tzartos SJ (2020) Myasthenia gravis: autoantibody specificities and their role in MG management. Front Neurol 11:596981. https:\/\/doi.org\/10.3389\/fneur.2020.596981","journal-title":"Front Neurol"},{"key":"12317_CR22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nri916","volume":"2","author":"A Vincent","year":"2002","unstructured":"Vincent A (2002) Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2:797\u2013804. https:\/\/doi.org\/10.1038\/nri916","journal-title":"Nat Rev Immunol"},{"key":"12317_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S et al (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365\u2013368. https:\/\/doi.org\/10.1038\/85520","journal-title":"Nat Med"},{"key":"12317_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.21037\/atm-19-363","volume":"11","author":"Y Li","year":"2023","unstructured":"Li Y, Peng Y, Yang H (2023) Serological diagnosis of myasthenia gravis and its clinical significance. Ann Transl Med. 11:290\u2013290. https:\/\/doi.org\/10.21037\/atm-19-363","journal-title":"Ann Transl Med."},{"key":"12317_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21037\/atm-20-2285","volume":"11","author":"W Zhu","year":"2023","unstructured":"Zhu W, Li K, Cui T, Yan Y (2023) Detection of anti-ganglioside antibodies in Guillain-Barr\u00e9 syndrome. Ann Transl Med 11:289\u2013289. https:\/\/doi.org\/10.21037\/atm-20-2285","journal-title":"Ann Transl Med"},{"key":"12317_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","volume":"6","author":"HJ Willison","year":"1999","unstructured":"Willison HJ, Veitch J, Swan AV, Baumann N, Comi G, Gregson NA et al (1999) Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol 6:71\u201377","journal-title":"Eur J Neurol"},{"key":"12317_CR27","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1038\/s41598-019-42545-8","volume":"9","author":"E Pascual-Go\u00f1i","year":"2019","unstructured":"Pascual-Go\u00f1i E, Mart\u00edn-Aguilar L, Lleix\u00e0 C et al (2019) Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy. Sci Rep 9:6155. https:\/\/doi.org\/10.1038\/s41598-019-42545-8","journal-title":"Sci Rep"},{"key":"12317_CR28","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","volume":"48","author":"A Vincent","year":"1985","unstructured":"Vincent A, Newsom-Davis J (1985) Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 48:1246\u20131252. https:\/\/doi.org\/10.1136\/jnnp.48.12.1246","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12317_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ana.20341","volume":"57","author":"H Shiraishi","year":"2005","unstructured":"Shiraishi H, Motomura M, Yoshimura T et al (2005) Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 57:289\u2013293. https:\/\/doi.org\/10.1002\/ana.20341","journal-title":"Ann Neurol"},{"key":"12317_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jocn.2005.04.028","volume":"13","author":"J-Y Lee","year":"2006","unstructured":"Lee J-Y, Sung JJ, Cho J-Y et al (2006) MuSK antibody-positive, seronegative myasthenia gravis in Korea. J Clin Neurosci 13:353\u2013355. https:\/\/doi.org\/10.1016\/j.jocn.2005.04.028","journal-title":"J Clin Neurosci"},{"key":"12317_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/jnnp.2006.100545","volume":"78","author":"X Zhang","year":"2006","unstructured":"Zhang X, Yang M, Xu J et al (2006) Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry 78:386\u2013390. https:\/\/doi.org\/10.1136\/jnnp.2006.100545","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12317_CR32","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"MI Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S et al (2008) IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis\u2020. Brain 131:1940\u20131952. https:\/\/doi.org\/10.1093\/brain\/awn092","journal-title":"Brain"},{"key":"12317_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1529-8027.2010.00278.x","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","unstructured":"Joint Task Force of the EFNS and the PNS (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline* on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Socie. J Peripher Nerv Syst 15:185\u2013195. https:\/\/doi.org\/10.1111\/j.1529-8027.2010.00278.x","journal-title":"J Peripher Nerv Syst"},{"key":"12317_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1529-8027.2010.00290.x","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","unstructured":"Joint Task Force of the EFNS and the PNS (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revis. J Peripher Nerv Syst 15:295\u2013301. https:\/\/doi.org\/10.1111\/j.1529-8027.2010.00290.x","journal-title":"J Peripher Nerv Syst"},{"key":"12317_CR35","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM et al (2021) European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force\u2014second revision. Eur J Neurol 28:3556\u20133583. https:\/\/doi.org\/10.1111\/ene.14959","journal-title":"Eur J Neurol"},{"key":"12317_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577288","volume":"345","author":"G Liberatore","year":"2020","unstructured":"Liberatore G, Giannotta C, Sajeev BP et al (2020) Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy. J Neuroimmunol 345:577288. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577288","journal-title":"J Neuroimmunol"},{"key":"12317_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/08916930008994083","volume":"32","author":"GM Ohanlon","year":"2000","unstructured":"Ohanlon GM, Veitch J, Gallardo E et al (2000) Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies. Autoimmunity 32:133\u2013144. https:\/\/doi.org\/10.3109\/08916930008994083","journal-title":"Autoimmunity"},{"issue":"4","key":"12317_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ana.410350416","volume":"35","author":"HJ Willison","year":"1994","unstructured":"Willison HJ, Paterson G, Kennedy PG, Veitch J (1994) Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann Neurol 35(4):471\u2013478","journal-title":"Ann Neurol"},{"key":"12317_CR39","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1515\/cclm-2018-0234","volume":"56","author":"D Franciotta","year":"2018","unstructured":"Franciotta D, Gastaldi M, Biagioli T et al (2018) Anti-ganglioside antibodies: experience from the Italian Association of Neuroimmunology external quality assessment scheme. Clin Chem Lab Med CCLM 56:1921\u20131925. https:\/\/doi.org\/10.1515\/cclm-2018-0234","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"10","key":"12317_CR40","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","volume":"43","author":"A Chiba","year":"1993","unstructured":"Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I (1993) Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies. Neurology 43(10):1911\u20131917","journal-title":"Neurology"},{"issue":"7","key":"12317_CR41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/01616412.1998.11740573","volume":"20","author":"K Mizoguchi","year":"1998","unstructured":"Mizoguchi K (1998) Anti-GQ1b IgG antibody activities related to the severity of Miller Fisher syndrome. Neurol Res 20(7):617\u2013624","journal-title":"Neurol Res"},{"issue":"2","key":"12317_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0165-5728(94)90042-6","volume":"50","author":"HJ Willison","year":"1994","unstructured":"Willison HJ, Veitch J (1994) Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol 50(2):159\u2013165","journal-title":"J Neuroimmunol"},{"key":"12317_CR43","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1093\/brain\/awf272","volume":"125","author":"HJ Willison","year":"2002","unstructured":"Willison HJ (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591\u20132625. https:\/\/doi.org\/10.1093\/brain\/awf272","journal-title":"Brain"},{"key":"12317_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jim.2014.05.005","volume":"408","author":"S Usuki","year":"2014","unstructured":"Usuki S, O\u2019Brien D, Rivner MH, Yu RK (2014) A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples. J Immunol Methods 408:52\u201363. https:\/\/doi.org\/10.1016\/j.jim.2014.05.005","journal-title":"J Immunol Methods"},{"issue":"9","key":"12317_CR45","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1212\/WNL.56.9.1227","volume":"56","author":"T Miyazaki","year":"2001","unstructured":"Miyazaki T, Kusunoki S, Kaida K, Shiina M, Kanazawa I (2001) Guillain-Barr\u00e9 syndrome associated with IgG monospecific to ganglioside GD1b. Neurology 56(9):1227\u20131229","journal-title":"Neurology"},{"issue":"1","key":"12317_CR46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/jnnp.69.1.136","volume":"69","author":"N Yuki","year":"2000","unstructured":"Yuki N, Susuki K, Hirata K (2000) Ataxic form of Guillain-Barr syndrome associated with anti-GD1b IgG antibody. J Neurol Neurosurg Psychiatry 69(1):136\u2013137","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12317_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jns.12359","volume":"25","author":"M Tagliapietra","year":"2020","unstructured":"Tagliapietra M, Zanusso G, Ferrari S et al (2020) Myelin uncompaction and axo-glial detachment in chronic ataxic neuropathy with monospecific IgM antibody to ganglioside GD1b. J Peripher Nerv Syst 25:54\u201359. https:\/\/doi.org\/10.1111\/jns.12359","journal-title":"J Peripher Nerv Syst"},{"key":"12317_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jns.12285","volume":"23","author":"NE Taams","year":"2018","unstructured":"Taams NE, Notermans NC, Fokkink WR et al (2018) Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies. J Peripher Nerv Syst 23:227\u2013234. https:\/\/doi.org\/10.1111\/jns.12285","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"12317_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0022-1759(93)90348-B","volume":"165","author":"F Chabraoui","year":"1993","unstructured":"Chabraoui F, Derrington EA, Mallie-Didier F, Confavreux C, Quincy C, Caudie C (1993) Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membranes. J Immunol Methods 165(2):225\u2013230","journal-title":"J Immunol Methods"},{"key":"12317_CR50","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3389\/fneur.2019.01385","volume":"10","author":"M Gastaldi","year":"2020","unstructured":"Gastaldi M, Zardini E, Scaranzin S et al (2020) Autoantibody diagnostics in neuroimmunology: experience from the 2018 italian neuroimmunology association external quality assessment program. Front Neurol 10:1385. https:\/\/doi.org\/10.3389\/fneur.2019.01385","journal-title":"Front Neurol"},{"issue":"2","key":"12317_CR51","first-page":"117","volume":"7","author":"MR Bonyadi","year":"2010","unstructured":"Bonyadi MR, Barzegar M, Badalzadeh R, Hashemilar M (2010) Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with guillain-barre syndrome. Iran J Immunol. 7(2):117\u2013123","journal-title":"Iran J Immunol."},{"issue":"6","key":"12317_CR52","first-page":"675","volume":"68","author":"C Caudie","year":"2023","unstructured":"Caudie C, Vial C, Petiot P, Bouhour F (2023) Les profils autoanticorps anti-gangliosides et anti-sulfatides associ\u00e9s aux neuropathies p\u00e9riph\u00e9riques: \u00e9valuation d\u2019un nouveau r\u00e9actif. Ann Biol Clin 68(6):675\u2013680","journal-title":"Ann Biol Clin"},{"issue":"2","key":"12317_CR53","first-page":"149","volume":"64","author":"C Caudie","year":"2023","unstructured":"Caudie C, Reymond A (2023) Les anticorps anti-glycolipides dans le diagnostic des neuropathies p\u00e9riph\u00e9riques auto-immunes par la technique Dotzen\u00ae Ganglio profile antibodies. Ann Biol Clin 64(2):149\u2013156","journal-title":"Ann Biol Clin"},{"issue":"11\u201312","key":"12317_CR54","first-page":"1277","volume":"59","author":"C Caudie","year":"2013","unstructured":"Caudie C, Quittard Pinon A, Bouhour F, Vial C, Garnier L, Fabien N (2013) Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies. Clin Lab 59(11\u201312):1277\u20131287","journal-title":"Clin Lab"},{"key":"12317_CR55","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1196\/annals.1398.031","volume":"1109","author":"K Conrad","year":"2007","unstructured":"Conrad K, Schneider H, Ziemssen T et al (2007) A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies. Ann N Y Acad Sci 1109:256\u2013264. https:\/\/doi.org\/10.1196\/annals.1398.031","journal-title":"Ann N Y Acad Sci"},{"key":"12317_CR56","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00277-014-2294-7","volume":"94","author":"G Talamo","year":"2015","unstructured":"Talamo G, Mir MA, Pandey MK et al (2015) IgM MGUS associated with anti-MAG neuropathy: a single institution experience. Ann Hematol 94:1011\u20131016. https:\/\/doi.org\/10.1007\/s00277-014-2294-7","journal-title":"Ann Hematol"},{"key":"12317_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10072-019-04089-7","volume":"41","author":"S Mat\u00e0","year":"2020","unstructured":"Mat\u00e0 S, Ambrosini S, Saccomanno D et al (2020) Anti-MAG IgM: differences in antibody tests and correlation with clinical findings. Neurol Sci 41:365\u2013372. https:\/\/doi.org\/10.1007\/s10072-019-04089-7","journal-title":"Neurol Sci"},{"key":"12317_CR58","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200038","volume":"10","author":"G Spagni","year":"2023","unstructured":"Spagni G, Gastaldi M, Businaro P et al (2023) Comparison of fixed and live cell-based assay for the detection of AChR and MuSK antibodies in myasthenia gravis. Neurol Neuroimmunol Neuroinflammation 10:e200038. https:\/\/doi.org\/10.1212\/NXI.0000000000200038","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"12317_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120084","volume":"432","author":"A Mirian","year":"2022","unstructured":"Mirian A, Nicolle MW, Edmond P, Budhram A (2022) Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis. J Neurol Sci 432:120084. https:\/\/doi.org\/10.1016\/j.jns.2021.120084","journal-title":"J Neurol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12317-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T10:25:34Z","timestamp":1720520734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12317-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["12317"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12317-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"3 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}